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The Clue to his Pancreatitis!
Malia Eischen, MD, Dale Dangleben, MD, FACS, Lehigh Valley Health Network, Allentown, Pennsylvania

Introduction

Discussion

Xanthomas are lesions characterized by accumulations of
lipid-laden macrophages. They are a common manifestation
of lipid metabolism disorders, including hyperliproteinemia
(HLP). HLPs have been classified according to 5 major phenotypes described in table 1. These phenotypes are based on
specific electrophoretic patterns seen in patients with elevated
lipoprotein levels. We present a case of a patient presenting
with gallstones and pancreatitis, initially misdiagnosed as
gallstone pancreatitis. His skin manifestations in combination
with an abnormal lab specimen clued us in to the correct
diagnosis.

The patient was managed in the ICU with IV fluids, pain
control, gemfibrozil/statin, and tight glycemic control for
approximately 3 weeks. He recovered from his pancreatitis
and was discharged home.
The plan is for an eventual cholecystectomy, but for now, he
requires tight control of his HLP.
He was diagnosed with Type III HLP, a serious disorder, with
lifelong consequences of premature vascular disease and
recurrent pancreatitis. Drug treatment (such as HMG-CoA
reductase inhibitors/other lipid-lowering drugs) is indicated
since dietary modifications alone are insufficient in managing
these patients.

Case
A 28-year-old male presented to the Emergency department
with abdominal pain. He had a CAT scan which showed
extensive peripancreatic edema and cholelithiasis. His
amylase and lipase levels were markedly elevated, but his
LFTs were normal. A diagnosis of gallstone pancreatitis was
made and the surgical service was consulted. Prior to
entering the room, we were cautioned that the patient had
a, “nasty” rash. On examination, he was found to have the
lesions shown on images 1 and 2. Subsequently, we were
called by the lab stating that the laboratory specimen was
lipemic (Image 3), and his triglyceride level was >5000 mg/
dL. This sent us to the textbooks, and we were quick to
realize that he had tuberoeruptive xanthomas, most likely
related to a form of HLP. He was later diagnosed with
type III HLP, which was considered the cause of his pancreatitis. Both medicine and endocrine were consulted and
the patient was transferred to the ICU.

Types of Hyperlipoproteinemia
Types
(Frederickson’s
hyperlipoproteinemia,
fat-induced hyperlipemia,
idiopathic familial)

1. Morganroth J, Levy R, Fredrickson D. The biochemical, clinical, and genetic features of type III
hyperlipoproteinemia. A nn Intern Med February 1975;82(2):158-174.
2. Cameron JL, Capuzzi DM, Zuidema GD, Margolis S. Acute pancreatitis with hyperlipemia: the incidence of
lipid abnormalities in acute pancreatitis. Ann Surg 1973 Apr;177(4):483-9.

Diagnostic findings

• Deﬁcient or abnormal lipoprotein lipase, resulting
in decreased or absent post heparin lipolytic
activity
• Relatively rare
• Present at birth

• Chylomicrons (very low density lipoprotein (VLDL), low
density lipotein (LDL), high density lipopro plasma 14
hours or more after last meal
• Highly elevated serum chylomicrons and triglyceride
levels, slightly elevated serum cholesterol levels
• Lower serum lipoprotein lipase levels
• Leukocytosis

• Deﬁcient cell surface receptors that regulate LDL,
degradation and cholesterol synthesis, resulting
in increased levels of plasma LDL over joints and
pressure points
• Onset between ages 10 and 30

• Increased plasma concentrations of LDL
• Increased serum LDL and cholesterol levels
• Amniocentesis shows increased LDL levels

• Unknown underlying defect results in deﬁcient
conversion of triglyceride rich VLDL to LDL
• Uncommon: usually occurs after age 20 but can
occur earlier in men

• Abnormal serum beta lipoprotein
• Elevated cholesterol and tryglyeride
• Slightly elevated glucose tolerance
• Hyperuricemia

• Usually occurs secondary to obesity, alcoholism,
diabetes, or emotional disorders
• Relatively common, especially in middle-aged
men

• Elevated VLDL levels
• Abnormal levels of triglycerides in plasma: variable
increase in serum
• Normal or slightly elevated serum cholesterol levels
• Mildly abnormal glucose tolerance
• Family history
• Early coronary artery disease

• Defective triglyceride clearance causes
pancreatitis usually secondary to another
disorder, such as obesity or nephrosis
• Uncommon: onset usually occurs in late
adolescence or early adulthood

• Chylomicrons in plasma
• Elevated plasma VLDV levels
• Elevated serum cholesterol and triglyceride levels

II
(Familial
hyperbetalipoproteinemia,
essential familial
hypercholesterolemia)
III
(Familial broad
beta disease,
dysbetalipoproteinemia,
remnant removal disease,
xanthomia tuberosum)
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IV

	
  

3

(Endogenous
hypertriglyceridemia,
hyperbetalipoproteinemia)
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V
(Mixed
hypertriglyceridemia
mixed hyperlipidemia)
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